Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.

MLA

Veiga, Diogo F. T., et al. “Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.” Frontiers in Immunology, vol. 13, Mar. 2022, p. 867443. EBSCOhost, https://doi.org/10.3389/fimmu.2022.867443.

APA

Veiga, D. F. T., Tremblay, M., Gerby, B., Herblot, S., Haman, A., Gendron, P., Lemieux, S., Zúñiga-Pflücker, J. C., Hébert, J., Cohen, J. P., & Hoang, T. (2022). Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia. Frontiers in Immunology, 13, 867443. https://doi.org/10.3389/fimmu.2022.867443

Chicago

Veiga, Diogo F T, Mathieu Tremblay, Bastien Gerby, Sabine Herblot, André Haman, Patrick Gendron, Sébastien Lemieux, et al. 2022. “Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.” Frontiers in Immunology 13 (March): 867443. doi:10.3389/fimmu.2022.867443.